Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. 1993

R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
Department of Otorhinolaryngology: Head and Neck Surgery, School of Medicine, University of Pennsylvania, Philadelphia.

Olfactory dysfunction occurs in most patients with idiopathic Parkinson's disease (PD). In this study, we sought to determine whether such dysfunction is also present in progressive supranuclear palsy (PSP), a condition which shares a number of motor symptoms with PD and is commonly misdiagnosed as PD. We administered the University of Pennsylvania Smell Identification Test, a standardized test of odor identification ability, to 21 PSP patients; 17 also received a forced-choice odor detection threshold test. We compared the olfactory test scores to those obtained from PD patients and normal controls matched to the PSP patients on the basis of age, sex, and smoking habits. Overall, the olfactory function of the PSP patients was markedly superior to that of the PD patients and did not differ significantly from that of the normal controls. There was no association in either the PSP or PD patient groups between (1) the olfactory test scores and (2) measures of motor symptom severity, disease stage, and medication usage. These findings demonstrate that patients with PSP and PD differ markedly in their ability to smell and suggest that olfactory testing may be useful in their differential diagnosis.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009812 Odorants The volatile portions of chemical substances perceptible by the sense of smell. Odors,Aroma,Fragrance,Scents,Aromas,Fragrances,Odor,Odorant,Scent
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012903 Smell The ability to detect scents or odors, such as the function of OLFACTORY RECEPTOR NEURONS. Olfaction,Sense of Smell,Smell Sense
D013494 Supranuclear Palsy, Progressive A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7) Ophthalmoplegia, Progressive Supranuclear,Progressive Supranuclear Ophthalmoplegia,Progressive Supranuclear Palsy 1,Steele-Richardson-Olszewski Syndrome,Palsy, Progressive Supranuclear,Progressive Supranuclear Palsy,Richardson's Syndrome,Steele-Richardson-Olszewski Disease,Supranuclear Palsy, Progressive, 1,Progressive Supranuclear Palsies,Richardson Syndrome,Steele Richardson Olszewski Disease,Steele Richardson Olszewski Syndrome,Supranuclear Ophthalmoplegia, Progressive,Supranuclear Palsies, Progressive

Related Publications

R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
January 2016, Frontiers in aging neuroscience,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
May 1985, Archives of internal medicine,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
January 1994, Journal of neural transmission. Supplementum,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
January 1999, Annals of neurology,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
April 2011, Nature reviews. Neurology,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
December 2008, Movement disorders : official journal of the Movement Disorder Society,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
June 1993, Hinyokika kiyo. Acta urologica Japonica,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
January 2017, Frontiers in neurology,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
August 2005, Movement disorders : official journal of the Movement Disorder Society,
R L Doty, and L I Golbe, and D A McKeown, and M B Stern, and C M Lehrach, and D Crawford
March 2016, Journal of neuropsychology,
Copied contents to your clipboard!